Genetic consequences of mass human chemotherapy for Schistosoma mansoni: Population structure pre-and post-praziquantel treatment in Tanzania

American Journal of Tropical Medicine and Hygiene

Volumn 83, Issue 4, 2010, Pages 951-957

  Norton, Alice J ^a,b   Gower, Charlotte M ^a   Lamberton, Poppy H L ^a   Webster, Bonnie L ^c   Lwambo, Nicholas J S ^d   Blair, Lynsey ^a   Fenwick, Alan ^a   Webster, Joanne P ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c DEPARTMENT OF LIFE SCIENCES   (United Kingdom)

^d NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; PRAZIQUANTEL; ANTISCHISTOSOMAL AGENT;

ARTICLE; CHILD; ENDEMIC DISEASE; FOLLOW UP; GENETIC ANALYSIS; GENETIC VARIABILITY; GROUPS BY AGE; HUMAN; MASS IMMUNIZATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE CLEARANCE; PARASITE EXAMINATION; PHYLOGENY; REINFECTION; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; TANZANIA; ANIMAL; CLINICAL TRIAL; CLUSTER ANALYSIS; DRUG EFFECT; GENETICS; SCHISTOSOMIASIS MANSONI; TIME;

SCHISTOSOMA MANSONI;

ANIMALS; CHILD; CLUSTER ANALYSIS; GENETIC VARIATION; HUMANS; PHYLOGENY; PRAZIQUANTEL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SCHISTOSOMICIDES; TANZANIA; TIME FACTORS;

EID: 79551616739     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2010.10-0283     Document Type: Article

References (30)

1. Hotez P, Raff S, Fenwick A, Richards F, Molyneux D, 2007. Recent progress in integrated neglected tropical disease control. Trends Parasitol 23: 511-514. (Pubitemid 350030912)
2. Fenwick A, Webster JP, 2006. Schistosomiasis: challenges for control, treatment and drug resistance. Curr Opin Infect Dis 19: 577-582. (Pubitemid 44665464)
3. Webster JP, Gower CM, Norton AJ, 2008. Application of evolutionary concepts to predicting and evaluating the impact of mass-chemotherapy schistosomiasis control programmes. Evolutionary Applications 1: 66-83.
4. King CH, Dickman K, Tisch DJ, 2005. Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 365: 1561-1569. (Pubitemid 40615405)
5. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J, 2006. Schistosomiasis and water resources development: systematic review, meta-analysis and estimates of people at risk. Lancet Infect Dis 6: 411-425. (Pubitemid 43949139)
6. Rollinson D, Kaukas A, Johnston DA, Simpson AJ, Tanaka M, 1997. Some molecular insights into schistosome evolution. Int J Parasitol 27: 11-28. (Pubitemid 27128367)
7. Agola LE, Mburu DN, DeJong RJ, Mungai BN, Muluvi GM, Njagi EN, Loker ES, Mkoji GM, 2006. Microsatellite typing reveals strong genetic structure of Schistosoma mansoni from localities in Kenya. Infect Genet Evol 6: 484-490. (Pubitemid 44542626)
8. Barral V, Morand S, Pointier JP, Theron A, 1996. Distribution of schistosome genetic diversity within naturally infected Rattus rattus detected by RAPD markers. Parasitology 113: 511-517. (Pubitemid 26393181)
9. Curtis J, Minchella D, 2000. Schistosome population genetic structure: when clumping worms is not just splitting hairs. Parasitol Today 16: 68-71. (Pubitemid 30089098)
10. Rollinson D, Webster JP, Nyakanna S, Stothard AJ Jr, 2009. Genetic diversity of schistosomes and snails: implications for control. Parasitology 136: 1801-1811.
11. Stothard JR, Webster BL, Weber T, Nyakaana S, Webster JP, Kazibwe F, Kabatereine NB, Rollinson D, 2009. Molecular epidemiology of Schistosoma mansoni in Uganda: DNA barcoding reveals substantive genetic diversity within Lake Albert and Lake Victoria populations. Parasitology 136: 1813-1824.
12. Colley DG, LoVerde PT, Savioli L, 2001. Infectious disease. Medical helminthology in the 21st century. Science 293: 1437-1438. (Pubitemid 32801534)
13. Fenwick A, Webster JP, Bosque-Oliva E, Blair L, Fleming FM, Zhang Y, Garba A, Stothard JR, Gabrielli AF, Clements AC, Kabatereine NB, Toure S, Dembele R, Nyandindi U, Mwansa J, Koukounari A, 2009. The Schistosomiasis Control Initiative (SCI): rational, development and implementation from 2002-2008. Parasitology 136: 1719-1730.
14. Doenhoff MJ, Kusel JR, Coles GC, Cioli D, 2002. Resistance of Schistosoma mansoni to praziquantel: is there a problem? Trans R Soc Trop Med Hyg 96: 465-469.
15. Doenhoff MJ, Pica-Mattoccia L, 2006. Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance. Expert Rev Anti Infect Ther 4: 199-210.
16. Danso-Appiah A, De Vlas SJ, 2002. Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal. Trends Parasitol 18: 125-129. (Pubitemid 34164257)
17. Alonso D, Munoz J, Gascon J, Valls ME, Corachan M, 2006. Failure of standard treatment with praziquantel in two returned travelers with Schistosoma haematobium infection. Am J Trop Med Hyg 74: 342-344. (Pubitemid 46774351)
18. Gower CM, Shrivastava J, Lamberton PH, Rollinson D, Emory A, Webster BL, Kabatereine NB, Webster JP, 2007. Development and application of an ethical and epidemiologically appropriate assay for the multi-locus microsatellite analysis of Schistosoma mansoni. Parasitology 134: 523-536. (Pubitemid 46340654)
19. Shrivastava J, Gower CM, Balolong E Jr, Wang TP, Qian BZ, Webster JP, 2005. Population genetics of multi-host parasites - the case for molecular epidemiological studies of Schistosoma japonicum using naturally sampled larval stages. Parasitology 131: 617-626. (Pubitemid 41577935)
20. Wang T-P, Shrivastava J, Johansen MV, Zhang ZK, Webster JP, 2006. Does multiple hosts mean multiple parasites? Population genetic structure of Schistosoma japonicum between definitive host species. Int J Parasitol 36: 1317-1325. (Pubitemid 44353487)
21. Curtis J, Sorensen RE, Minchella DJ, 2002. Schistosome genetic diversity: the implications of population structure as detected with microsatellite markers. Parasitology 125: S51-S59. (Pubitemid 36207779)
22. Durand P, Sire C, Theron A, 2000. Isolation of microsatellite markers in the digenetic trematode Schistosoma mansoni from Guadeloupe Island. Mol Ecol 9: 997-998. (Pubitemid 30466716)
23. Blair L, Webster JP, Barker GC, 2001. Isolation and characterization of polymorphic microsatellite markers in Schistosoma mansoni from Africa. Mol Ecol Notes 1: 93-95. (Pubitemid 33691859)
24. Lui K, Muse S, 2005. PowerMarker: integrated analysis environment for genetic marker data. Bioinformatics 21: 2128-2129. (Pubitemid 40668066)
25. Goudet J, 1995. Fstat version 1.2: a computer program to calculate F-statistics. J Hered 86: 485-486.
26. Cavalli-Sforza LL, Edwards AW, 1967. Phylogenetic analysis. Models and estimation procedures. Am J Hum Genet 19: 233-257.
27. Langella O, 1999. Populations 1.2.28 genetic software. CNRS CNRS UPR9034. Available at: www.cnrs-gif.fr/pge.
28. Lewis PO, Zaykin D, 2001. Genetic data analysis: computer program for the analysis of allelic data, version 1. 1.
29. Ardelli BF, Guerriero SB, Pritchard RK, 2006. Ivermectin imposes selection pressure on P-glycoprotein from Onchocerca volvulus : linkage disequilibrium and genotype diversity. Parasitology 132: 370-386.
30. Correa-Oliveira R, Caldas IR, Martins-Filho OA, Queiroz CC, Lambertucci JR, Cunha-Melo JR, Silveira AS, Prata A, Wilson A, Gazzinelli G, 2000. Analysis of the effects of treatment of human Schistosoma mansoni infection on the immune response of patients in endemic areas. Acta Trop 77: 141-146.